Why XOM Stock surged +2.16% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, XOM scores 71 out of 100, a letter grade of B-, with the verdict label "Roarable Buy — Sound Institutional Accumulation." The five pillars are: Fundamental Cash Engine at 14/20 (ROIC 9.9%; FCF yield 2.51%), Whale 13F Flow at 13/20 (institutional accumulation and options positioning), Insider Conviction at 14/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 16/20 (beta 0.28; sector sensitivity), and Forensic Balance Sheet at 14/20 (Altman Z 4.65; Piotroski F 4/9; Debt/Equity 0.19). The highest-scoring pillar is Macro Regime Fit, which reflects the low beta reported in the market data. The lowest-scoring pillars are Whale 13F Flow, and the Fundamental Cash Engine and Insider Conviction and Forensic Balance Sheet pillars (each at 14). For a prospective investor, the rating points to a stock with a comparatively low reported beta and solid forensic metrics, offset by a modest free-cash-flow yield and a trailing P/E of 29.6 against a forward P/E of 15.1. The gap between trailing and forward earnings multiples is a valuation tradeoff the investor would need to evaluate against the earnings trajectory. This is an educational summary of the scoring, not a recommendation.

Per the SEC financials, quarterly operating income and net income declined from Q2 2025 through Q1 2026, and reported debt rose from $38989.0M to $47661.0M across the same window while cash fell from $14352.0M to $8435.0M. The market data reports an operating margin of 11.0% and a net margin of 7.6%, and a gross margin of 0%. Per the Roarable RQD rating, the Forensic Balance Sheet pillar cites an Altman Z-Score of 4.65, a Piotroski F-Score of 4/9, and a Debt/Equity ratio of 0.19, and the Fundamental pillar cites ROIC of 9.9%. The source data does not give a full balance-sheet reconciliation to explain the debt and cash movement, so the reported trend should be read as a figure set rather than a conclusion.

Per the Butterfly Supply-Chain Graph, the critical customer exposure is to airlines, marine bunkering and fuel wholesalers (listed as DAL), with 58% revenue exposure tied to refining and marketing throughput of approximately 5.4M bbl/d. The polymer and packaging customer group (listed as AMZN) carries HIGH criticality at 18% revenue exposure. On the supplier side, oilfield services (SLB and Halliburton) are CRITICAL at 34% revenue exposure, tied to upstream capital and exploration spending of $27B+ per year, and Baker Hughes and SBM Offshore (BKR) are CRITICAL at 24% exposure for LNG turbomachinery and Guyana FPSO vessels. Competitor concentration includes Chevron (CVX, CRITICAL, 92%), Shell and TotalEnergies (SHEL, HIGH, 80%), and ConocoPhillips (COP, HIGH, 45%). The second-order risk an investor would watch is concentration: the graph shows a heavy dependence on a critical customer group for refined product and on a small set of critical service and project-execution partners for the Guyana and LNG program. Per the graph, the butterfly links are empty, so no quantified cross-ticker ripple is reported.

Per the analyst data, the consensus breakdown is 8 Buy, 19 Hold, and 0 Sell, with 5 Strong Buy ratings. The target mean is $215.77 and the target median is $215.96, with a target low of $193.87 and a target high of $232.44. The Street Bs Score is 80 and the implied upside is 15.23%. Recent individual calls include Bernstein SocGen Group (REITERATE, OUTPERFORM, price target $212.59), J.P. Morgan (TARGET REV, OUTPERFORM, $219.33), UBS (REITERATE, BUY, $205.85), Bank of America Securities (UPGRADE, STRONG BUY, $230.94), Evercore ISI (UPGRADE, STRONG BUY, $232.44), Citigroup (UPGRADE, OUTPERFORM, $211.47), Goldman Sachs (TARGET REV, STRONG BUY, $225.32), Morgan Stanley (UPGRADE, OUTPERFORM, $220.08), Jefferies (REITERATE, BUY, $205.85), and Barclays (TARGET REV, HOLD, $193.87). Per the holders data, reported trades include: Rep. Mark Green (Congressional PTR, BUY, 3,200 shares at $168.94, filed 2026-10-21); Berkshire Hathaway (13F, BUY, 2,100,000 shares at $160.59, filed 2026-10-14); The Vanguard Group (13F, BUY, 1,525,624 shares, filed 2026-10-12); BlackRock (13F, BUY, 1,161,795 shares, filed 2026-10-04); Sen. Tommy Tuberville (Congressional PTR, BUY, 2,800 shares at $165.99, filed 2026-09-24); FMR LLC (13F, BUY, 843,223 shares, filed 2026-08-31); Coatue Management (13F, BUY, 633,641 shares, filed 2026-07-28); and Citadel Advisors (13F, BUY, 1,450,000 shares, filed 2026-04-21). No SEC Form 4 insider sale or purchase entries are present in the holders data.